Health

STAT+: What stands between brain implants and FDA approval?

STAT+: HHS adviser hopes prior authorization reform happens in ‘double-digit months,’ not years

STAT+: Digital twins, the holy grail of preventative health, are still only a ‘Frankensteinian proof of principle’

STAT+: In earnings call, Hims CEO addresses scrutiny of GLP-1 compounding  

STAT+: A provocative proposal asks the FDA to let some AI devices on the market without review

STAT+: An AI startup floats FDA deregulation, using an obscure backdoor

STAT+: AI-guided cancer treatments, telehealth usage, and other health tech news

STAT+: Hims to buy Eucalyptus as it looks to expand globally